Search
for
Sort by
Research 91–120 of 1000+
- Are finasteride-related penile curvature/Peyronie’s disease Adverse Event Reports worthy of further clinical investigation? Disproportionality analysis based on both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases
- Endocrine care of transpeople part I. A review of cross-sex hormonal treatments, outcomes and adverse effects in transmen
- Beliefs and counseling practices among dermatologists regarding sexual and other adverse effects of finasteride
- Finasteride Use Is Associated with Higher Odds of Obstructive Sleep Apnea: Results from the US Food and Drug Administration Adverse Events Reporting System.
- Finasteride Use Is Associated with Higher Odds of Obstructive Sleep Apnea: Results from the US Food and Drug Administration Adverse Events Reporting System.
- 004 Post Finasteride Syndrome: is Dutasteride Unfairly Accused?
- Efficacy and Safety of Finasteride Therapy for Androgenetic Alopecia
- En pacientes jóvenes, el uso de finasteride podría asociarse con mayor riesgo de ansiedad, depresión y eventos adversos relacionados con el suicidio
- 054 Post Finasteride Syndrome: Guess Who-Demographics from FDA Database
- Adverse effects of finasteride in men treated for benign prostatic hyperplasia and androgenetic alopecia - a literature review
- Retrospective Pharmacotherapeutic Evaluation of Dutasteride not Approved by US FDA for Androgenetic Alopecia in Korea
- Sexual dysfunction in men taking systemic dermatologic medication: A systematic review
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Finasteride and Dutasteride for the Treatment of Male Androgenetic Alopecia: A Review of Efficacy and Reproductive Adverse Effects
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
- Finasteride Use: Evaluation of Depression and Suicide Risk
- Signal Detection of Depression and Suicidality Associated with Finasteride and Dutasteride: Updated Pharmacovigilance Evidence and Recommendations for Comprehensive Psychiatric Assessment
- Treatment Strategies for Cutaneous and Oral Mucosal Side Effects of Oncological Treatment in Breast Cancer: A Comprehensive Review
- Acupuncture for treating alopecia areata: A systematic review and meta-analysis
- 5‐alpha‐reductase inhibitor treatment for frontal fibrosing alopecia: an evidence‐based treatment update
- Implementing patient safety and quality improvement in dermatology. Part 1: Patient safety science
- Patient-reported treatment outcomes and safety of direct-to-consumer teledermatology for finasteride treatment in male androgenetic alopecia: A cross-sectional study
- The Impact of the 5α-Reductase Inhibitors (5α-RIs) on Male Sexual Function and Psychological Well-Being
- Effects of 5-alpha reductase inhibitors
- Penile vascular abnormalities in young men with persistent side effects after finasteride use for the treatment of androgenic alopecia
- Adverse effects of 5α-reductase inhibitors: What do we know, don’t know, and need to know?
- Which chemicals should be grouped together for mixture risk assessments of male reproductive disorders?
- Adverse Effects of 5-Alpha-Reductase Inhibitors: a narrative review
- 104 Flibanserin Subset Analyses and the Androgenics of Hypoactive Sexual Desire Disorder
- Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation